| Literature DB >> 26987686 |
Harold Oliva1, Rodrigo Pacheco2,3, José M Martinez-Navio4, Marta Rodríguez-García1,5, Mar Naranjo-Gómez6, Núria Climent1, Carolina Prado3, Cristina Gil1, Montserrat Plana1, Felipe García1,7, José M Miró1,7, Rafael Franco4,8, Francesc E Borras9,10, Naveenan Navaratnam11, José M Gatell1,7, Teresa Gallart1,5.
Abstract
APOBEC3G (apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3G; A3G) is an innate defense protein showing activity against retroviruses and retrotransposons. Activated CD4(+) T cells are highly permissive for HIV-1 replication, whereas resting CD4(+) T cells are refractory. Dendritic cells (DCs), especially mature DCs, are also refractory. We investigated whether these differences could be related to a differential A3G expression and/or subcellular distribution. We found that A3G mRNA and protein expression is very low in resting CD4(+) T cells and immature DCs, but increases strongly following T-cell activation and DC maturation. The Apo-7 anti-A3G monoclonal antibody (mAb), which was specifically developed, confirmed these differences at the protein level and disclosed that A3G is mainly cytoplasmic in resting CD4(+) T cells and immature DCs. Nevertheless, A3G translocates to the nucleus in activated-proliferating CD4(+) T cells, yet remaining cytoplasmic in matured DCs, a finding confirmed by immunoblotting analysis of cytoplasmic and nuclear fractions. Apo-7 mAb was able to immunoprecipitate endogenous A3G allowing to detect complexes with numerous proteins in activated-proliferating but not in resting CD4(+) T cells. The results show for the first time the nuclear translocation of A3G in activated-proliferating CD4(+) T cells.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26987686 DOI: 10.1038/icb.2016.28
Source DB: PubMed Journal: Immunol Cell Biol ISSN: 0818-9641 Impact factor: 5.126